NCT02630914View on ClinicalTrials.gov

Medical and Surgical Hybrid Treatment of Atrial Fibrillation.

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

March 31, 2018

Conditions
Atrial Fibrillation (AF)
Interventions
DEVICE

The AtriCure Synergy Ablation System

The AtriCure Synergy Ablation System will be used on all patients for AF ablation.

Trial Locations (1)

31059

University Hospital Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT02630914 - Medical and Surgical Hybrid Treatment of Atrial Fibrillation. | Biotech Hunter | Biotech Hunter